These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 27789681)

  • 1. Estrogen Signaling as a Therapeutic Target in Neurodevelopmental Disorders.
    Crider A; Pillai A
    J Pharmacol Exp Ther; 2017 Jan; 360(1):48-58. PubMed ID: 27789681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Estrogen Receptors and Their Signaling across Psychiatric Disorders.
    Hwang WJ; Lee TY; Kim NS; Kwon JS
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Serotonin Receptors in Neurodevelopmental Disorders: Focus on 5-HT7 Receptor.
    Lee J; Avramets D; Jeon B; Choo H
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34199418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglia along sex lines: From brain colonization, maturation and function, to implication in neurodevelopmental disorders.
    Bordeleau M; Carrier M; Luheshi GN; Tremblay MÈ
    Semin Cell Dev Biol; 2019 Oct; 94():152-163. PubMed ID: 31201858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAM10 as a therapeutic target for brain diseases: from developmental disorders to Alzheimer's disease.
    Marcello E; Borroni B; Pelucchi S; Gardoni F; Di Luca M
    Expert Opin Ther Targets; 2017 Nov; 21(11):1017-1026. PubMed ID: 28960088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does environmental exposure to the greenhouse gas, N
    Fluegge K
    Environ Toxicol Pharmacol; 2016 Oct; 47():6-18. PubMed ID: 27566494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of altered pyramidal cell morphology on clinical symptoms of neurodevelopmental disorders.
    Asad Z; Fakheir Y; Abukhaled Y; Khalil R
    Eur J Neurosci; 2024 Sep; 60(5):4877-4892. PubMed ID: 39054743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of estrogen in sex differences in memory, emotion and neuropsychiatric disorders.
    Iqbal J; Huang GD; Xue YX; Yang M; Jia XJ
    Mol Biol Rep; 2024 Mar; 51(1):415. PubMed ID: 38472517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and molecular mechanisms of neurodevelopmental disorders.
    Ghiani CA; Faundez V
    J Neurosci Res; 2017 May; 95(5):1093-1096. PubMed ID: 28225560
    [No Abstract]   [Full Text] [Related]  

  • 10. Challenges and opportunities for precision medicine in neurodevelopmental disorders.
    Chen GT; Geschwind DH
    Adv Drug Deliv Rev; 2022 Dec; 191():114564. PubMed ID: 36183905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal deficits in neurodevelopmental disorders.
    Li Y; Shen M; Stockton ME; Zhao X
    Neurobiol Learn Mem; 2019 Nov; 165():106945. PubMed ID: 30321651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Connecting the Neurobiology of Developmental Brain Injury: Neuronal Arborisation as a Regulator of Dysfunction and Potential Therapeutic Target.
    Goikolea-Vives A; Stolp HB
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodevelopmental and Neuropsychiatric Disorders.
    Traetta ME; Chaves Filho AM; Akinluyi ET; Tremblay MÈ
    Adv Neurobiol; 2024; 37():457-495. PubMed ID: 39207708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamate mediated signaling in the pathophysiology of autism spectrum disorders.
    Choudhury PR; Lahiri S; Rajamma U
    Pharmacol Biochem Behav; 2012 Feb; 100(4):841-9. PubMed ID: 21756930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of environmental estrogens on Yfish considering the diversity of estrogen signaling.
    Segner H; Casanova-Nakayama A; Kase R; Tyler CR
    Gen Comp Endocrinol; 2013 Sep; 191():190-201. PubMed ID: 23763869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Microglia in Neurodevelopmental Disorders and their Therapeutics.
    Coomey R; Stowell R; Majewska A; Tropea D
    Curr Top Med Chem; 2020; 20(4):272-276. PubMed ID: 32091337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 15q13.3 deletion syndrome: Deficient α(7)-containing nicotinic acetylcholine receptor-mediated neurotransmission in the pathogenesis of neurodevelopmental disorders.
    Deutsch SI; Burket JA; Benson AD; Urbano MR
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():109-17. PubMed ID: 26257138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Role of Microtubule Stabilizing Agents in Neurodevelopmental Disorders.
    Bonini SA; Mastinu A; Ferrari-Toninelli G; Memo M
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28933765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Estrogens against Alzheimer disease? The female sexual hormone as a protective neurohormone].
    Behl C
    MMW Fortschr Med; 2001 May; 143 Suppl 2():33-5. PubMed ID: 11434254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms underlying estrogen-induced sexual differentiation in the hypothalamus.
    Ohtani-Kaneko R
    Histol Histopathol; 2006 Mar; 21(3):317-24. PubMed ID: 16372252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.